Skip to main content

Evaluation of a Custom Three-Dimensional Surgical Guide in Mandibular Sagittal Split Osteotomy: An Exploratory Split-Mouth Randomized Controlled Trial

Journal
Orthodontics & craniofacial research (Q1)
Published
16 July 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Evy Eida Vitria, Revini Nuita, Muhammad Kamil Hassan, Nissia Ananda, Tan Wui Jing, Zakiah Mat Ripen, et al.
PMID
42464006
DOI
10.1111/ocr.70163

Why clinicians should know about it

  • Picked for Otorhinolaryngology (top studies of the week, 19 July 2026): Custom 3D guide improves mandibular split osteotomy outcomes

Abstract

OBJECTIVE: This exploratory split-mouth randomized controlled trial aimed to evaluate the effect of a custom three-dimensional (3D) surgical guide on mandibular sagittal split osteotomy outcomes compared with conventional freehand osteotomy. METHODS: Patients undergoing sagittal split osteotomy (SSO) were randomly assigned in a split-mouth design to receive mandibular osteotomy performed with a custom-made 3D surgical guide on one side and without a surgical guide on the contralateral side. The primary outcome was the postoperative lingual split scale (LSS) of the mandible. Secondary outcomes were lateral osteotomy end (LOE), assessed using postoperative CT-based evaluation, and intraoperative inferior alveolar nerve exposure (NE). RESULTS: Fifteen patients contributed 30 mandibular sides for paired analysis. Guided sides showed more favourable LSS (p = 0.041) and LOE (p = 0.041) distributions compared with non-guided sides. No statistically significant difference was observed in NE (p = 0.763). These findings suggest that the use of a custom 3D surgical guide may improve osteotomy control and split predictability. CONCLUSION: The custom 3D surgical guide was associated with more favourable lingual split pattern and lateral osteotomy end distributions during sagittal split osteotomy. Given that the study population consisted predominantly of skeletal Class III patients, these findings should be interpreted primarily within the context of Class III patients. No significant reduction in intraoperative inferior alveolar nerve exposure was observed.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.